-+ 0.00%
-+ 0.00%
-+ 0.00%

Aptevo Therapeutics Reports Q2 2025 Net Loss of $6.2M, EPS at $8.40, Compared to $5.9M Loss and $1,236.96 EPS in Q2 2024

Reuters·08/11/2025 12:10:47

Please log in to view news